<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Novus Therapeutics Announces First Patient Enrolled in Phase 2a Clinical Trial of Anti-CD40L Antibody AT-1501 in Amyotrophic Lateral Sclerosis	</title>
	<atom:link href="https://www.alsfindingacure.org/novus-therapeutics-announces-first-patient-enrolled-in-phase-2a-clinical-trial-of-anti-cd40l-antibody-at-1501-in-amyotrophic-lateral-sclerosis/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.alsfindingacure.org/novus-therapeutics-announces-first-patient-enrolled-in-phase-2a-clinical-trial-of-anti-cd40l-antibody-at-1501-in-amyotrophic-lateral-sclerosis/</link>
	<description>Our sole mission is to fund ALS research to find a cure.</description>
	<lastBuildDate>Tue, 07 Sep 2021 16:21:02 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>
</channel>
</rss>
